Literature DB >> 8310383

Facial nerve outcome after acoustic neuroma surgery.

S L Nutik1.   

Abstract

Factors influencing facial nerve preservation and function in acoustic neuroma surgery were studied in 108 cases. Anatomic preservation of the nerve was inversely related to tumor size and improved as the series progressed. When the nerve was saved, normal postoperative function was inversely related to tumor size and was more common if the cochlear nerve was also saved. Most intact nerves eventually recovered some function, but late function was seldom completely normal unless there was some early recovery. The results demonstrate the importance of tumor size, operator experience, and ease of dissection on facial nerve outcome.

Entities:  

Mesh:

Year:  1994        PMID: 8310383     DOI: 10.1016/0090-3019(94)90204-6

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  4 in total

1.  Tumors of the cerebellopontine angle. Changing policy in treatment.

Authors:  M Horváth; B Bábel; I Nyáry; J Vajda; S Czirják; I Gádor
Journal:  Neurosurg Rev       Date:  1996       Impact factor: 3.042

2.  Koos grade IV vestibular schwannomas: considerations on a consecutive series of 60 cases-searching for the balance between preservation of function and maximal tumor removal.

Authors:  Luciano Mastronardi; Alberto Campione; Fabio Boccacci; Carlo Giacobbo Scavo; Ettore Carpineta; Guglielmo Cacciotti; Raffaelino Roperto; Albert Sufianov; Ali Zomorodi
Journal:  Neurosurg Rev       Date:  2021-02-18       Impact factor: 3.042

3.  Current results of the surgical management of acoustic neuroma.

Authors:  Sun H Lee; Thomas O Willcox; William A Buchheit
Journal:  Skull Base       Date:  2002-11

4.  Microsurgical treatment of symptomatic vestibular schwannomas in patients under 40: different results before and after age of 30.

Authors:  Luciano Mastronardi; Alberto Campione; Guglielmo Cacciotti; Ettore Carpineta; Carlo Giacobbo Scavo; Raffaele Roperto; Giovanni Stati; Albert A Sufianov; Karl Schaller
Journal:  Neurosurg Rev       Date:  2021-08-17       Impact factor: 3.042

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.